MEDAPP S.A. ZY -10 (WQ1) - Total Liabilities

Latest as of December 2025: €13.06 Million EUR ≈ $15.27 Million USD

Based on the latest financial reports, MEDAPP S.A. ZY -10 (WQ1) has total liabilities worth €13.06 Million EUR (≈ $15.27 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore WQ1 net assets growth trend to track the company's year-over-year net asset growth rate.

MEDAPP S.A. ZY -10 - Total Liabilities Trend (2021–2025)

This chart illustrates how MEDAPP S.A. ZY -10's total liabilities have evolved over time, based on quarterly financial data. See MEDAPP S.A. ZY -10 free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

MEDAPP S.A. ZY -10 Competitors by Total Liabilities

The table below lists competitors of MEDAPP S.A. ZY -10 ranked by their total liabilities.

Company Country Total Liabilities
Spacetalk Ltd
AU:SPA
Australia AU$12.86 Million
Culpeo Minerals Ltd
AU:CPO
Australia AU$133.18K
Foresight Group Holdings Limited
LSE:FSG
UK GBX79.08 Million
JIADE LIMITED Common stock
NASDAQ:JDZG
USA $23.23 Million
Torq Resources Inc
V:TORQ
Canada CA$5.61 Million
ExGen Resources Inc
V:EXG
Canada CA$115.41K
Longvie SA
BA:LONG
Argentina AR$16.05 Billion
Sentra Food Indonesia Tbk PT
JK:FOOD
Indonesia Rp65.76 Billion

Liability Composition Analysis (2021–2025)

This chart breaks down MEDAPP S.A. ZY -10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MEDAPP S.A. ZY -10 stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.86 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.55 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.33 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how MEDAPP S.A. ZY -10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for MEDAPP S.A. ZY -10 (2021–2025)

The table below shows the annual total liabilities of MEDAPP S.A. ZY -10 from 2021 to 2025.

Year Total Liabilities Change
2025-12-31 €13.06 Million
≈ $15.27 Million
+12.49%
2024-12-31 €11.61 Million
≈ $13.57 Million
+29.10%
2023-12-31 €8.99 Million
≈ $10.51 Million
+81.81%
2022-12-31 €4.95 Million
≈ $5.78 Million
-31.61%
2021-12-31 €7.23 Million
≈ $8.46 Million
--

About MEDAPP S.A. ZY -10

F:WQ1 Germany Health Information Services
Market Cap
$6.73 Million
€5.75 Million EUR
Market Cap Rank
#27968 Global
#2403 in Germany
Share Price
€0.02
Change (1 day)
+0.00%
52-Week Range
€0.01 - €0.07
All Time High
€0.26
About

MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D… Read more